期刊文献+

疾病管理对冠心病患者二级预防的影响 被引量:4

Effects of management programm on secondary prevention for patients with coronary heart disease
原文传递
导出
摘要 目的探索冠心病疾病管理计划的可行性和对冠心病二级预防的影响。方法将397例冠心病患者随机分为2组,干预组203例,对照组194例。干预组干预包括6次健康教育、电话随访、专科门诊等,观察12月后2组患者的临床指标以及药物使用等变化情况。结果随访12月,干预组吸烟率(3.4%比29.9%),体质量指数(22.7±1.19比23.7±1.34)和有氧运动比例(63.1%比31.9%)与对照组比较,均有显著差异(P均<0.01)。干预组血压达标率(88.2%比77.8%),糖化血红蛋白(Hb A1c)达标率(85.7%比66.5%),和LDL水平变化[(-24.1±20.4)%比(-18.4±23.5)%]与对照组比较,差异均有统计学意义(P<0.05或P<0.01)。除血管紧张素转换酶抑制剂/血管紧张素受体拮抗剂(ACEI/ARBs)外,干预组服药依从性显著优于对照组(P<0.05)。干预组总心血管病事件发生率(20.2%)显著低于对照组(40.7%),差异有统计学意义(P<0.01)。结论冠心病疾病管理计划可显著改善冠心病患者的生活方式,提高血压、Hb A1c、LDL达标率,增加服药依从性,显著降低远期心血管病事件发生率。 Objective To investigate the feasibility and effects of disease management programm for secondary prevention in patients with coronary heart disease( CHD). Methods From May 2012 to May 2013,397 patients diagnosed as CHD were randomly allocated to intervention group( n = 203) and control group( n = 194). Patients in the intervention group received health education,telephone follow-up and cardiovascular department. Patients were followed for 12 months.Results After 12 months follow-up,there were significant differences between the intervention group and control group in smoking rate( 3. 4% vs. 29. 9%),BMI( 22. 7 ± 1. 19 vs. 23. 7 ± 1. 34) and the proportion of exercise regularly( 63. 1% vs. 31. 9%),patients with blood pressure less than 140 /90 mm Hg( 88. 2% vs. 77. 8%),glycosylated hemoglobin less than 7%( 85. 7% vs. 66. 5%),and the reduction of low density lipoprotein( LDL) [(- 24. 1 ± 20. 4) % vs.(-18. 4 ± 23. 5) %]. The reported intake of medications was higher in intervention group than in control group,except for ACEI / ARBs. Cardiovascular event rate of intervention group and control group was 20. 2% and 40. 7% respectively( P〈0. 01). Conclusions Disease management programm for CHD can improve life styles,improve compliance to CHD treatment and reduce the accurance rate of cardiovascular event.
出处 《实用老年医学》 CAS 2015年第4期294-296,299,共4页 Practical Geriatrics
关键词 冠心病 疾病管理计划 二级预防 生活方式 coronary heart disease disease management programm second prevention life style
  • 相关文献

参考文献12

  • 1Newby LK, Lapointe NM, Chen AY, et al. Long-term ad- herence to evidence-based secondary prevention therapies in coronary artery disease [ J ]. Circulation, 2006, 113 (2) : 203-212.
  • 2胡大一."生命网"——他汀降胆固醇的新模式和服务系统[J].中国医药导刊,2004,6(6):468-469. 被引量:20
  • 3Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA Focused update of the guideline for the management of pa- tients with unstable angina/non-ST-elevation myocardial in- farction (updating the 2007 guideline and replacing the 2011focuse update) [ J ]. Circulation, 2012, 126 (7) : 875-910.
  • 4O'Garar PT, Kushner FG, Ascheim DD, et al. 2013ACCR/ AHA guideline for the management of ST-elevation myocardial infarction [ J ]. Circulation, 2013, 12 ( 4 ) : e362-e425.
  • 5陈韵岱.随访门诊——“生命网畅通无阻的关键”[J].中国医药导刊,2003,5(4):310-311. 被引量:7
  • 6Smith SC, Allen JJ, Blair SN, et al. AHA/ACC gudielines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the national heart, lung, and blood institute [ J ]. J Am Coil Cardiol, 2006, 47( 10): 2130-2139.
  • 7Cannon CP, Brindis RG, Chaiman BR, et al. 2013ACCF/ AHA key data elements and definitions for measuring the clinical management and outcomes of patents with acute coronary syndromes and coronary artery disease[ J]. Circula- tion, 2013, 127(9) : 1052-1089.
  • 8Bhatt DL, Steg PG, Ohman EM, et al. International preva- lence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis [ J ]. JAMA, 2006, 295(10) : 180-189.
  • 9Gonseth J, Guallar-Castillon P, Banegas JR, et al. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports [ J ]. Eur Heart J, 2004, 25(18) :1570-1595.
  • 10Otsu H, Moriyama M. Effectiveness of an educational self-management programe for outpatients with chronic heart failure [ J]. Jpn J Nurs Sei, 2011, 8 (2) : 140-152.

二级参考文献15

  • 1贾建平.神经病学[M]6版北京:人民卫生出版社,2008:176.
  • 2Hernandez AF, Greiner MA, Fonarow GC, et al.Relationship between early physician follow-up and 30-dayreadmission among medicare beneficiaries hospitalized forheart failure[J]. JAMA, 2010,303(17) : 1716-1722.
  • 3Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHAguideline for the management of heart failure : a report of theAmerican College of Cardiology Foundation/American HeartAssociation Task Force on Practice Guidelines [ J ]. J AmColl Cardiol, 2013,62(16) :el47-e239.
  • 4Yancy CW, Jessup M,Bozkurt B,et al. 2013 ACCF/AHAguideline for the management of heart failure : executivesummary : a report of the American College of CardiologyFoundation/American Heart Association Task Force on prac-tice guidelines[ J]. Circulation, 2013 ,128( 16) : 1810-1852.
  • 5Scherr D,Kastner P, Kollmann A, et al. Effect of home-based telemonitoring using mobile phone technology on theoutcome of heart failure patients after an episode of acute de-compensation :randomized controlled trial [ J ] .J Med InternetRes, 2009,11(3): e34.
  • 6Seto E, Leonard KJ, Cafazzo JA, et al. Mobile phone-basedtelemonitoring for heart failure management : a randomizedcontrolled trial[ J]. J Med Internet Res, 2012,14( 1) : e31.
  • 7无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3691
  • 8中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2009,29(6):602-604. 被引量:530
  • 9钱方毅.老年心力衰竭治疗的循证医学研究进展[J].实用老年医学,2009,23(5):344-349. 被引量:4
  • 10中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010,43(2):154-160. 被引量:953

共引文献28

同被引文献38

  • 1Alnouri F, Wood D, Kotseva K, et al.Which statin worked best to achieve lipid level targets in a European registry? A post-hoc analysis of the EUROASPIRE IIl for coronary heart disease patients [ J]. J Saudi Heart Assoc, 2014,26 (4) : 183-91.
  • 2Rogge BP, Cramariuc D, Ionnebakken MT, et al. Effect of overweight and obesity on cardiovascular events in asympto- matic aortic stenosis: a SEAS substudy (Simvastatin Ezetimibe in Aortic Stenosis)[ J]. J Am Coll Cardiol, 2013, 62 (18) : 1683-1690.
  • 3Har R, Scholey JW, Daneman D, et al.The effect of renal hy- perfihration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes metlitus [ J ]. Diabetologia, 2013,56 (5) : 1166-1173.
  • 4Abe M, Maruyama N, Okada K, et al. Effects of lipid- lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy [ J ]. J Atheroscler Thromb, 2011,18 ( 11 ) : 1018-1028.
  • 5Hong YJ, Jeong MH, Choi YH, et al. Usual dose of simvas- tatin does not inhibit plaque progression and lumen loss at the peri-stent reference segments after bare-metal stent im- plantation: a serial intravascular ultrasound analysis[ J]. Ko- rean J Intern Med, 2010, 25(4) :356-363.
  • 6Goel K,Lennon RJ,Tilbury RT,et al.Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneouscronary intervention in the community[J].Circul ation,2011,123(21):2344-2352.
  • 7Fleenor BS,Marshall KD,Durrant JR,et al.Arterial stiffening with ageing is associated with transforming growth factor-β1-related changes in adventitial collagen:reversal by aerobic exercise[J].J Physiol,2010,588(Pt 20):3971-3982.
  • 8Batista DF,Goncalves AF,Rafacho BP,et al.Delayed rather than early exercise training attenuates ventricular remodeling after myocardial infarction[J].Int J Cardiol,2013,170(1):e3-e4.
  • 9Nocon M,Hiemann T,Muller-Riemenschnerder F,et al.Association of physical activity with all-cause and cardiovascular mortality:a systematic review and meta-analysis[J].Eur JCardiovasc Prev Rehabil,2008,15(3):239-246.
  • 10皇甫宁,朱建华.冠心病二级预防药物治疗现状调查[C].浙江省心电生理与起搏学术年会,2014.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部